The potential for correction of depressive disorders in patients with chronic obstructive pulmonary disease

Cover Page

Cite item

Abstract

Background: The use of vitamin D in the treatment of depressive disorders in patients with chronic obstructive pulmonary disease (COPD) is justified by its pathophysiology, but it is not always feasible in clinical practice. This may be related to the lack of guidelines for implementation for this patient group, as well as to the inadequate sample of patients with baseline high vitamin D levels or mild psychoemotional distress.

Objective: To assess the changes of psychoemotional status over time in COPD patients against the maintenance of vitamin D levels at>34.3 ng/ml for one year.

Materials and methods: The study included 264 COPD patients randomized into the treatment and control groups (135 and 129 patients, respectively). The patients in both groups were divided into 4 subgroups according to their forced expiratory volume in 1 second (FEV1) values and vitamin D levels. All the patients were administered an inactive vitamin D (colecalciferol): in the main group, according to the scheme ensuring maintenance of the micronutrient value above the goal for 12 months, and in the control group according to the standard scheme of correction of vitamin D deficiency. Depression symptoms were assessed in Geriatric Depression Scale (GDS-15) at the beginning of the study and at its end.

Results: After 12 months of vitamin D treatment, the main group showed a statistically significant decrease in the rate of severe depression (14.8% vs 6.7%, χ2=4.67, p=0.04) and an increase in the proportion of patients with normal psychoemotional status (28.2% vs 49.6%, χ2=13.11, p=0.03). In addition, there was a significant difference between the rates of severe depression in the main and control groups after 12 months of treatment: 6.7% vs 14.7% (χ2=4.52, p=0.02).

Conclusion: Maintenance of vitamin D levels above 34.3 ng/ml in COPD patients for 12 months reduces the proportion of patients with severe depression.

About the authors

E. V. Bolotova

Kuban State Medical University

Email: fake@neicon.ru
ORCID iD: 0000-0001-6257-354X

Elena V. Bolotova - MD, PhD, Professor, Chair of Therapy No. 1, Faculty of Advanced Training and Retraining of Specialists.

4 Sedina ul., Krasnodar, 350063

Russian Federation

A. V. Dudnikova

Kuban State Medical University

Author for correspondence.
Email: avdudnikova@yandex.ru
ORCID iD: 0000-0003-2601-7831

Anna V. Dudnikova - MD, PhD, Internist, Consultative-Diagnostic Department, Clinic.

4/1 Zipovskaya ul., Krasnodar, 350010,  Tel.: +7 (918) 471 21 22

Russian Federation

V. V. Trembach

Regional Clinical Hospital No. 2

Email: rahill_de_novo@mail.ru
ORCID iD: 0000-0002-1463-2610

Valeria V. Trembach - MD, PhD, Endocrinologist, Department of Endocrinology.

6/2 Krasnykh partizan ul., Krasnodar, 3500124 Tel.: +7 (918) 471 21 22

Russian Federation

References

  1. Global Initiative for Chronic Obstructive Lung Disease [Internet]. Available from: https://goldcopd.org/.
  2. Lutsey PL, Chen N, Mirabelli MC, Lakshmina-rayan K, Knopman DS, Vossel KA, Gottesman RF, Mosley TH, Alonso A. Impaired Lung Function, Lung Disease, and Risk of Incident Dementia. Am J Respir Crit Care Med. 2019;199(11):1385-96. doi: 10.1164/rccm.201807-1220OC.
  3. Jolliffe DA, Greenberg L, Hooper RL, Mathys-sen C, Rafiq R, de Jongh RT, Camargo CA, Griffiths CJ, Janssens W, Martineau AR. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019;74(4):337-45. doi: 10.1136/thoraxjnl-2018-212092.
  4. Sluyter JD, Camargo CA Jr, Stewart AW, Waay-er D, Lawes CMM, Toop L, Khaw KT, Thom SAM, Hametner B, Wassertheurer S, Parker KH, Hughes AD, Scragg R. Effect of Monthly, High-Dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy. J Am Heart Assoc. 2017;6(10):e006802. doi: 10.1161/JAHA.117.006802.
  5. Davison KM, Lung Y, Lin SL, Tong H, Kobayashi KM, Fuller-Thomson E. Depression in middle and older adulthood: the role of immigration, nutrition, and other determinants of health in the Canadian longitudinal study on aging. BMC Psychiatry. 2019;19(1):329. doi: 10.1186/s12888-019-2309-y.
  6. Yavuz YC, Biyik Z, Ozkul D, Abusoglu S, Eryavuz D, Dag M, Korez MK, Guney I, Altin-tepe L. Association of depressive symptoms with 25(OH) vitamin D in hemodialysis patients and effect of gender. Clin Exp Nephrol. 2020;24(1):63-72. doi: 10.1007/s10157-019-01794-7.
  7. Iyer AS, Bhatt SP, Garner JJ, Wells JM, Trevor JL, Patel NM, Kirkpatrick D, Williams JC, Dransfield MT. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016;13(2):197-203. doi: 10.1513/AnnalsATS.201507-439OC.
  8. Alavi NM, Khademalhoseini S, Vakili Z, Assari-an F. Effect of vitamin D supplementation on depression in elderly patients: A randomized clinical trial. Clin Nutr. 2019;38(5):2065-70. doi: 10.1016/j.clnu.2018.09.011.
  9. Пигарова ЕА, Рожинская ЛЯ, Белая ЖЕ, Дзеранова ЛК, Каронова ТЛ, Ильин АВ, Мельниченко ГА, Дедов ИИ. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых. Проблемы эндокринологии. 2016;62(4):60-84. doi: 10.14341/probl201662460-84.
  10. Болотова ЕВ, Являнская ВВ, Дудникова АВ. Предикторы развития больших кардиоваскулярных событий у больных хронической обструктивной болезнью легких в сочетании с ранними стадиями хронической болезни почек. Кардиология. 2019;59(3S):52-60. doi: 10.18087/cardio.2539.
  11. Болотова ЕВ, Являнская ВВ, авторы, правообладатели. Система расчета времени достижения целевого уровня витамина D у больных хронической обструктивной болезнью легких в сочетании с ранними стадиями дисфункции почек. Свид. 2019612850 Рос. Федерация. Опубл. 01.03.2019
  12. Malakouti SK, Fatollahi P, Mirabzadeh A, Salavati M, Zandi T. Reliability, validity and factor structure of the GDS-15 in Iranian elderly. Int J Geriatr Psychiatry. 2006;21(6): 588-93. doi: 10.1002/gps.1533.
  13. Kidney Disease: Improving Global Outcomes. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease [Internet]. Kidney International Supplements. 2013;3(1). 150 p. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.
  14. Инюткина НВ, Шатохина ИС. Определение протеинурии: какой метод выбрать? Справочник заведующего клинико-диагностической лабораторией. 2015;(4):33-9.
  15. Matte DL, Pizzichini MM, Hoepers AT, Diaz AP, Karloh M, Dias M, Pizzichini E. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154-61. doi: 10.1016/j.rmed.2016.06.006.
  16. Gowda U, Mutowo MP, Smith BJ, Wluka AE, Renzaho AM. Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials. Nutrition. 2015;31(3): 421-9. doi: 10.1016/j.nut.2014.06.017.
  17. Yalamanchili V, Gallagher JC. Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause. 2012;19(6):697-703. doi: 10.1097/gme.0b013e31823bcec5.
  18. Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J, Li L, Cao S, Lu Z. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14:371. doi: 10.1186/s12888-014-0371-z.
  19. Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, Kanter J, Escudero V, Romero R, Pal-lardo LM. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol DialTransplant. 2014;29(1):97-109. doi: 10.1093/ndt/gft360.
  20. Krairittichai U, Mahannopkul R, Bunnag S. An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. J Med Assoc Thai. 2012;95 Suppl 3:S41-7.
  21. de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol. 2013;24(11):1863-71. doi: 10.1681/ASN.2013030203.
  22. Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D. Impact of vitamin D supplementation on arterial vaso-motion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One. 2014;9(3):e91363. doi: 10.1371/journal.pone.0091363.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2020 Bolotova E.V., Dudnikova A.V., Trembach V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies